Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy–obstacles and perspectives
J Procházková, Z Kahounová, J Vondráček… - …, 2024 - Taylor & Francis
Aryl hydrocarbon receptor (AhR) is a transcription factor that is primarily known as an
intracellular sensor of environmental pollution. After five decades, the list of synthetic and …
intracellular sensor of environmental pollution. After five decades, the list of synthetic and …
Liquid biopsy: from concept to clinical application
C Alix-Panabières, D Marchetti, JE Lang - Scientific Reports, 2023 - nature.com
The diagnosis and treatment of cancer presents a physical and mental burden to the patient,
often involving diagnostic biopsies and surgeries or chemotherapeutic approaches with …
often involving diagnostic biopsies and surgeries or chemotherapeutic approaches with …
Trop2-Targeted Molecular Imaging in Solid Tumors: Current Advances and Future Outlook
Y Liu, W Huang, RJ Saladin, JC Hsu… - Molecular …, 2024 - ACS Publications
Trophoblast cell surface antigen 2 (Trop2), a transmembrane glycoprotein, plays a dual role
in physiological and pathological processes. In healthy tissues, Trop2 facilitates …
in physiological and pathological processes. In healthy tissues, Trop2 facilitates …
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
Distinguishing indolent from clinically significant localized prostate cancer is a major clinical
challenge and influences clinical decision-making between treatment and active …
challenge and influences clinical decision-making between treatment and active …
[PDF][PDF] Targeting Trop-2 as a Cancer Driver
E Guerra, M Trerotola, S Alberti - Journal of Clinical Oncology, 2023 - ricerca.unich.it
The Trop-2–targeting antibody-drug conjugate (ADC) sacituzumab govitecan (SG) has been
approved by the US Food and Drug Administration and European Medicines Agency for …
approved by the US Food and Drug Administration and European Medicines Agency for …
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
Therapeutic approaches targeting proteins on the surface of cancer cells have emerged as
an important strategy for precision oncology. To capitalize on the potential impact of drugs …
an important strategy for precision oncology. To capitalize on the potential impact of drugs …
[HTML][HTML] Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma
M Chen, Y Gao, H Cao, Z Wang, S Zhang - Heliyon, 2024 - cell.com
Background Epithelial cell adhesion molecule (EpCAM), a well-established marker for
circulating tumor cells, plays a crucial role in the complex process of cancer metastasis. The …
circulating tumor cells, plays a crucial role in the complex process of cancer metastasis. The …
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape
C Yang, L Wang, C Gong, D Lv, H Li… - Oncology …, 2025 - spandidos-publications.com
The global incidence of prostate cancer (PCa) is rising. Localized PCa can be managed
through surgical intervention or radiotherapy, but certain patients may experience …
through surgical intervention or radiotherapy, but certain patients may experience …
Immunotherapy combinations for metastatic castration-resistant prostate cancer–failed trials and future aspects
SF Slovin - Current Opinion in Urology, 2023 - journals.lww.com
Immunotherapy with checkpoint inhibitors alone or in combination with a variety of agents
such as chemotherapy, poly-ADP ribose polymerase (PARP) inhibitors or novel biologics …
such as chemotherapy, poly-ADP ribose polymerase (PARP) inhibitors or novel biologics …
[HTML][HTML] Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates
A Ajkunic, E Sayar, MP Roudier, RA Patel… - Research …, 2023 - ncbi.nlm.nih.gov
Therapeutic approaches targeting proteins on the surface of cancer cells have emerged as
an important strategy for precision oncology. To fully capitalize on the potential impact of …
an important strategy for precision oncology. To fully capitalize on the potential impact of …